{"meta":{"query_hash":"ecc0c43e4fe9","filters":{"venue":"Treatments in Respiratory Medicine"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ecc0c43e4fe9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Treatments+in+Respiratory+Medicine"},"results":[{"id":"W1007717218","doi":"10.2165/00151829-200605020-00007","title":"Asthma Mortality in Portugal","year":2006,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Asthma; Poisson regression; Mortality rate; Inhaled corticosteroids; Population; Demography; Internal medicine; Pediatrics; Environmental health","score_opus":0.035961320185219976,"score_gpt":0.3421836048564142,"score_spread":0.3062222846711942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1007717218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96970135,0.0045948974,0.00016130527,0.0017530993,0.00020778045,0.000025326968,0.010161437,0.000042722084,0.013352142],"genre_scores_gemma":[0.994156,0.0011613098,0.000059470738,0.000120526776,0.00010130717,0.00001757539,0.0028961096,0.000013252705,0.0014743897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913895,0.00018025967,0.00008254935,0.00017688071,0.00012897255,0.0002922986],"domain_scores_gemma":[0.9991103,0.00009158369,0.00036827958,0.00006065529,0.00010436559,0.00026483036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043747723,0.00036209336,0.00060687977,0.0015152856,0.000595179,0.001120586,0.00048955187,0.00086725474,0.0038523101],"category_scores_gemma":[0.0015498644,0.00034258774,0.001393473,0.0017268873,0.00026591826,0.00041776197,0.0009956971,0.0007749138,0.0005071916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005250344,0.00014620015,0.98409665,0.00019605785,0.00020705842,0.00088896,0.00031775536,0.0003741075,0.00038976595,0.00051941467,0.0022940892,0.010044917],"study_design_scores_gemma":[0.000012011639,0.000036959587,0.9976313,0.000042016076,0.00002573874,0.00030214095,0.00030800674,0.000117005875,0.00004177551,0.00006280045,0.0014150128,0.000005221578],"about_ca_topic_score_codex":0.02913078,"about_ca_topic_score_gemma":0.031309083,"teacher_disagreement_score":0.02913078,"about_ca_system_score_codex":0.0016488385,"about_ca_system_score_gemma":0.0009968645,"threshold_uncertainty_score":0.057922482},"labels":[],"label_agreement":null},{"id":"W1543609398","doi":"10.2165/00151829-200403030-00004","title":"Therapeutic Response to Asthma Medications","year":2004,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Asthma; Pharmacogenetics; Medicine; Single-nucleotide polymorphism; Leukotriene; Drug; Pharmacogenomics; Genotype; Pharmacology; Bioinformatics; Internal medicine; Genetics; Biology","score_opus":0.08200167292792823,"score_gpt":0.42445623763929935,"score_spread":0.34245456471137115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543609398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014966265,0.99709487,0.00013803951,0.00020742428,0.00020781753,0.000014536676,0.000032884578,0.000010250884,0.00214457],"genre_scores_gemma":[0.0016330511,0.99594456,0.00033445715,0.0005091457,0.0002774563,0.000020006268,0.000079406185,0.0000020910948,0.0011997885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954,0.000089239744,0.00008008658,0.00006311658,0.0001944836,0.00003317998],"domain_scores_gemma":[0.99962676,0.00018145854,0.000098641394,0.0000133519015,0.00006035569,0.000019495164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005740632,0.0010092162,0.002906127,0.0024220184,0.00024852183,0.00096165756,0.0010599893,0.001083581,0.007039739],"category_scores_gemma":[0.0010332504,0.00028608443,0.0012298162,0.0016437325,0.0003395733,0.0007100831,0.00057618594,0.002103373,0.0027297917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002093193,0.00011268392,0.00025608236,0.018351827,0.00025987206,0.00022113418,0.000028269671,0.00021383366,0.0015348078,0.0010600631,0.021661941,0.95609003],"study_design_scores_gemma":[0.00035033477,0.00037542445,0.004375073,0.01422002,0.0011696406,0.0030426004,0.00006842407,0.00025657355,0.0011150697,0.0015308072,0.97346187,0.000034113986],"about_ca_topic_score_codex":0.0010088183,"about_ca_topic_score_gemma":0.0021278104,"teacher_disagreement_score":0.007039739,"about_ca_system_score_codex":0.00049870985,"about_ca_system_score_gemma":0.0007528196,"threshold_uncertainty_score":0.023550212},"labels":[],"label_agreement":null},{"id":"W1558740640","doi":"10.2165/00151829-200504030-00002","title":"As-Needed Inhaled ??2-Adrenoceptor Agonists in??Moderate-to-Severe Asthma","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Asthma; B2 receptor; Salmeterol; Adrenergic beta-Agonists; Bronchodilator Agents; Pharmacy; β2 adrenergic receptor; Adrenergic receptor; Pharmacology; Intensive care medicine; Internal medicine; Agonist; Bronchodilator; Receptor; Family medicine","score_opus":0.06736567119802928,"score_gpt":0.4013126014408081,"score_spread":0.33394693024277883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558740640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019491972,0.9986594,0.0000700096,0.00015825432,0.00021581347,0.000011771384,0.000028946904,0.000004242,0.0006566165],"genre_scores_gemma":[0.0017617826,0.9965766,0.00020988953,0.0003687029,0.0002606051,0.000019462943,0.000050286704,0.0000010821128,0.0007515261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997584,0.00005382634,0.00006488673,0.000029239487,0.00007445119,0.00001923158],"domain_scores_gemma":[0.99974686,0.00012666627,0.0000744191,0.0000053512963,0.00002987188,0.00001683771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052018446,0.00066001894,0.0026535906,0.001494974,0.00017601105,0.0005610053,0.0006617965,0.0008749603,0.005242247],"category_scores_gemma":[0.0006999599,0.0002701055,0.00088431855,0.00113083,0.00021578805,0.0006693725,0.0003614932,0.0012430323,0.0013701121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043473422,0.00010812673,0.0002065258,0.045132793,0.00046964525,0.00030295234,0.00004204406,0.00017216739,0.0015000268,0.0008348823,0.02450012,0.92629594],"study_design_scores_gemma":[0.00095273624,0.0007074921,0.0047940067,0.022235038,0.0026406508,0.0037519836,0.00013667687,0.00023276276,0.0010615889,0.0010685016,0.9623816,0.000037013553],"about_ca_topic_score_codex":0.00088850904,"about_ca_topic_score_gemma":0.0039143013,"teacher_disagreement_score":0.005242247,"about_ca_system_score_codex":0.00034752185,"about_ca_system_score_gemma":0.00064237474,"threshold_uncertainty_score":0.017537117},"labels":[],"label_agreement":null},{"id":"W1579434571","doi":"10.2165/00151829-200605060-00009","title":"A Review of New Fluoroquinolones","year":2006,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Gatifloxacin; Moxifloxacin; Medicine; Levofloxacin; Gemifloxacin; Ciprofloxacin; Chronic bronchitis; Streptococcus pneumoniae; Respiratory tract infections; Pharmacology; Community-acquired pneumonia; Pneumonia; Intensive care medicine; Internal medicine; Antibiotics; Microbiology; Respiratory system","score_opus":0.160405219300709,"score_gpt":0.4512480902019646,"score_spread":0.2908428709012556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579434571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095405834,0.9991899,0.00007431489,0.00009475659,0.000118608856,0.000006884166,0.000026097208,0.000006078622,0.00038785415],"genre_scores_gemma":[0.00037326396,0.99874735,0.00027568612,0.00016149358,0.00013497141,0.0000068711297,0.00003435997,9.5139654e-7,0.00026500243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996927,0.00004786944,0.00008670409,0.000045293054,0.00010489994,0.000022597003],"domain_scores_gemma":[0.9995142,0.00022535291,0.00011707735,0.000010043369,0.00009855883,0.00003473288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006737107,0.00125125,0.0028105099,0.003967873,0.00028611717,0.0010297068,0.001235828,0.0011115094,0.0044361656],"category_scores_gemma":[0.0009513462,0.00044598788,0.00091050833,0.0035101555,0.00036718923,0.0015511055,0.0005483467,0.001416282,0.0013590817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023969685,0.00011593215,0.00017978234,0.045962133,0.0002769108,0.00039820702,0.00004970043,0.00027972215,0.0016271406,0.00078266783,0.029196696,0.9208913],"study_design_scores_gemma":[0.00017445364,0.0004155511,0.0020015307,0.012768596,0.0009649107,0.0031034066,0.00008454494,0.00018204047,0.0006722266,0.0007380691,0.97884744,0.000047135214],"about_ca_topic_score_codex":0.0017488827,"about_ca_topic_score_gemma":0.004322736,"teacher_disagreement_score":0.0044361656,"about_ca_system_score_codex":0.0005809161,"about_ca_system_score_gemma":0.0012216804,"threshold_uncertainty_score":0.014840424},"labels":[],"label_agreement":null},{"id":"W1604459260","doi":"10.2165/00151829-200403010-00002","title":"Management of Exercise-Induced Bronchospasm in Children","year":2004,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Bronchospasm; Asthma; Leukotriene; Placebo; Crossover study; Randomized controlled trial; Montelukast; Salmeterol; Antagonist; Anesthesia; Pharmacology; Internal medicine; Alternative medicine","score_opus":0.09332393725907137,"score_gpt":0.41735591182408455,"score_spread":0.3240319745650132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1604459260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017328373,0.99942744,0.000048673923,0.00006248985,0.00006125326,0.000005363655,0.000008431465,0.000002526026,0.00021056582],"genre_scores_gemma":[0.001305311,0.99813217,0.00018417869,0.00010959366,0.00009519592,0.000009078536,0.000020640327,6.951523e-7,0.0001431488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997664,0.00004461111,0.000061208215,0.0000400263,0.00006968758,0.000017969938],"domain_scores_gemma":[0.9996151,0.00023522145,0.00008739474,0.0000058668875,0.00003899986,0.000017474833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004817294,0.00078341935,0.0026772616,0.0017326345,0.00021314184,0.00065708417,0.0010229388,0.0009376776,0.0023155182],"category_scores_gemma":[0.000930122,0.00028922127,0.0010925647,0.0011255613,0.00029927347,0.0006445131,0.00040673144,0.0014311391,0.00054312113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028082705,0.00017227292,0.00051885325,0.054542836,0.00062873005,0.00071091636,0.00006058074,0.00032638965,0.0014653648,0.00048775648,0.008934054,0.9318715],"study_design_scores_gemma":[0.0014493625,0.002010733,0.02254093,0.07937369,0.0066143037,0.019941393,0.0005680932,0.00069702114,0.0025788837,0.0017786789,0.8623196,0.00012736332],"about_ca_topic_score_codex":0.0016604814,"about_ca_topic_score_gemma":0.0040992517,"teacher_disagreement_score":0.0026772616,"about_ca_system_score_codex":0.00035549098,"about_ca_system_score_gemma":0.0007081095,"threshold_uncertainty_score":0.0077462196},"labels":[],"label_agreement":null},{"id":"W1971189120","doi":"10.2165/00151829-200403050-00005","title":"Pharmacologic Treatments for Acute Respiratory Distress Syndrome and Acute Lung Injury","year":2004,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Acute respiratory distress; Intensive care medicine; Diffuse alveolar damage; Respiratory system; Anesthesia; Lung; Internal medicine","score_opus":0.08427969464831135,"score_gpt":0.4478155977993939,"score_spread":0.36353590315108253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971189120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119548255,0.9977998,0.00017309774,0.00023214541,0.00023621126,0.000017403534,0.000023383578,0.000009499163,0.0013888965],"genre_scores_gemma":[0.0007400627,0.99735415,0.00036634115,0.000291868,0.00025486815,0.00002458348,0.000030303961,0.0000014035412,0.0009364003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978906,0.000038963666,0.000050171097,0.000031032563,0.000075321914,0.000015410069],"domain_scores_gemma":[0.99955124,0.0002210698,0.00011779971,0.00001217318,0.00006871917,0.000028909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047462346,0.0012106264,0.0023695268,0.0029589394,0.00036523922,0.00079320703,0.0008934916,0.0012515569,0.0065065897],"category_scores_gemma":[0.0009600121,0.00038578306,0.00064035726,0.0022371376,0.00045303436,0.0012205482,0.00052885205,0.0021678787,0.0022550207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012251166,0.00016519333,0.000114218594,0.017064793,0.0001341013,0.00018634109,0.00003142276,0.0001794922,0.0011344879,0.0010181458,0.023719665,0.9561296],"study_design_scores_gemma":[0.00028584452,0.0005238367,0.0025315455,0.011442475,0.0008711857,0.0028868353,0.000092371716,0.0002162315,0.00086928054,0.0014042978,0.9788385,0.000037641857],"about_ca_topic_score_codex":0.0012506347,"about_ca_topic_score_gemma":0.004267047,"teacher_disagreement_score":0.0065065897,"about_ca_system_score_codex":0.0004916593,"about_ca_system_score_gemma":0.0010330402,"threshold_uncertainty_score":0.021766722},"labels":[],"label_agreement":null},{"id":"W1977525832","doi":"10.2165/00151829-200605050-00006","title":"Economic Burden of Ambulatory and Home-Based Care for Adults with Cystic Fibrosis","year":2006,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Foundation for Healthcare Improvement; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Ambulatory care; Ambulatory; Health care; Economic cost; Cost–benefit analysis; Family medicine; Pharmacy; Total cost; Cystic fibrosis; Indirect costs; Environmental health; Business; Economic growth; Internal medicine","score_opus":0.012805608557760133,"score_gpt":0.30016479416262987,"score_spread":0.2873591856048697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977525832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538884,0.00760913,0.00018055928,0.020459771,0.00030189927,0.00005982251,0.0040729498,0.000014174011,0.013413287],"genre_scores_gemma":[0.993669,0.0027357703,0.00018084193,0.0007763334,0.00020715347,0.000023491915,0.0012093784,0.0000034976638,0.0011946444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908555,0.0004049021,0.00008493014,0.000029456425,0.00020621903,0.00018900601],"domain_scores_gemma":[0.9983405,0.00025248845,0.00057173625,0.00002711076,0.00021732658,0.0005908078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052144687,0.00015870944,0.00028854536,0.0005428916,0.0006009959,0.00070087437,0.00026744712,0.00078138773,0.003930063],"category_scores_gemma":[0.004171839,0.00013316327,0.00077344675,0.0007673655,0.0003250718,0.0005508851,0.00096806954,0.0010258822,0.0001688832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020475907,0.000505095,0.8652662,0.0003036085,0.0005047844,0.0015039741,0.0005656493,0.0013901105,0.00051863014,0.003637154,0.025298998,0.09845821],"study_design_scores_gemma":[0.00012629475,0.0003880792,0.98553675,0.00020814581,0.00018720291,0.0012681457,0.0015641279,0.0016379105,0.00006851618,0.0004755075,0.008523676,0.000015654781],"about_ca_topic_score_codex":0.028815696,"about_ca_topic_score_gemma":0.058676235,"teacher_disagreement_score":0.028815696,"about_ca_system_score_codex":0.0022742026,"about_ca_system_score_gemma":0.0019231187,"threshold_uncertainty_score":0.05729592},"labels":[],"label_agreement":null},{"id":"W1977850256","doi":"10.2165/00151829-200504010-00005","title":"Development and Validation of a Patient Satisfaction and Preference Questionnaire for Inhalation Devices","year":2005,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Inhalation; Pharmacy; Patient satisfaction; Preference; Anesthesia; Family medicine; Nursing; Statistics","score_opus":0.05297625380434497,"score_gpt":0.31713979386852736,"score_spread":0.2641635400641824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977850256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97564214,0.00050904806,0.015006705,0.0006901945,0.00014197752,0.003729872,0.00083657657,0.00007420064,0.0033692452],"genre_scores_gemma":[0.95147014,0.00048733986,0.039730255,0.0008874052,0.00008383658,0.0037995928,0.0015974847,0.000051165352,0.0018928547],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9893963,0.0050993604,0.0018125112,0.00037365672,0.0029674708,0.00035080314],"domain_scores_gemma":[0.9722649,0.015569758,0.0035817425,0.0009908038,0.006818611,0.0007741988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016790653,0.00042810434,0.0008622166,0.0011231472,0.0005465327,0.00089655776,0.00071834325,0.0009493343,0.0018621517],"category_scores_gemma":[0.021744758,0.00033530762,0.00150448,0.00072243175,0.0005830181,0.000863382,0.0010172655,0.0013266172,0.0006021988],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004270504,0.0069802743,0.70604223,0.0008017465,0.00065810984,0.00036327975,0.0054191235,0.0018068859,0.026322607,0.0011187019,0.004556951,0.24165946],"study_design_scores_gemma":[0.0012434963,0.015514173,0.948259,0.00019331569,0.0003419243,0.001411157,0.0032892905,0.0076728035,0.010549964,0.00035780566,0.011013179,0.0001538542],"about_ca_topic_score_codex":0.0011884437,"about_ca_topic_score_gemma":0.0016377408,"teacher_disagreement_score":0.016790653,"about_ca_system_score_codex":0.00086915825,"about_ca_system_score_gemma":0.0014475563,"threshold_uncertainty_score":0.08879852},"labels":[],"label_agreement":null},{"id":"W200048665","doi":"10.2165/00151829-200605060-00010","title":"Corticosteroid Insensitivity in Smokers??with??Asthma","year":2006,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Asthma and Lung UK; CYTED Ciencia y Tecnología para el Desarrollo; Heart and Stroke Foundation of Canada","keywords":"Medicine; Asthma; Corticosteroid; Smoking cessation; Population; Tobacco smoke; Lung function; Internal medicine; Pediatrics; Lung; Environmental health; Pathology","score_opus":0.022010884247661643,"score_gpt":0.2942633432877309,"score_spread":0.2722524590400693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W200048665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820539,0.0052170507,0.00013465546,0.0012425705,0.00022417391,0.000021105845,0.0002296687,0.000030591375,0.010846309],"genre_scores_gemma":[0.9975247,0.00076673535,0.000041248037,0.0003277745,0.0001268097,0.0000035427593,0.0000818962,0.000005290721,0.0011221252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962926,0.000109639506,0.000038437345,0.000051241317,0.00007611909,0.00009514951],"domain_scores_gemma":[0.9987993,0.000572283,0.00020821724,0.00007266078,0.00008275733,0.0002647131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045844508,0.0002353426,0.00044299077,0.0007284384,0.00044601766,0.00046235384,0.00026680072,0.0008057718,0.0057318876],"category_scores_gemma":[0.0035082062,0.00021611007,0.00043400226,0.0003530249,0.00039266417,0.0003804035,0.00025417627,0.0010024685,0.00059766194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008272117,0.00082908664,0.8942796,0.000183827,0.00033670216,0.01941497,0.0005648283,0.0000935501,0.01409274,0.00044590433,0.0020092477,0.059477564],"study_design_scores_gemma":[0.00008928135,0.0011400896,0.9742433,0.000045710825,0.00027405086,0.018915068,0.00037840498,0.00018933407,0.0020426766,0.0005231689,0.0021378722,0.000020963238],"about_ca_topic_score_codex":0.0030987996,"about_ca_topic_score_gemma":0.004072328,"teacher_disagreement_score":0.0057318876,"about_ca_system_score_codex":0.0003577984,"about_ca_system_score_gemma":0.0003128138,"threshold_uncertainty_score":0.019175053},"labels":[],"label_agreement":null},{"id":"W2001563499","doi":"10.2165/00151829-200504040-00005","title":"The Role of Tiotropium Bromide, a Long-Acting Anticholinergic Bronchodilator, in the Management of COPD","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Tiotropium bromide; Medicine; Ipratropium bromide; Anticholinergic; COPD; Bronchodilator; Anesthesia; Salmeterol; Tolerability; Ipratropium; Adverse effect; Intensive care medicine; Bronchodilation; Pharmacology; Asthma; Internal medicine; Lung; Lung function","score_opus":0.06414578480112251,"score_gpt":0.39838503235523826,"score_spread":0.3342392475541157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001563499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005782489,0.9994573,0.000039134302,0.000102574166,0.000063058294,0.000002998567,0.000008413492,0.0000018769904,0.00026679374],"genre_scores_gemma":[0.00029159064,0.9992974,0.00011835256,0.000080921694,0.000052580977,0.0000026733014,0.000010967174,3.8530266e-7,0.00014514681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996735,0.000053698925,0.00007046807,0.00004508537,0.00013789361,0.000019483252],"domain_scores_gemma":[0.99934,0.0003762021,0.000117814125,0.00001118236,0.00011658445,0.00003809245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010141404,0.0008718021,0.0025417735,0.0028372582,0.00033160913,0.0010402333,0.001144903,0.0012065185,0.0031517718],"category_scores_gemma":[0.0012356385,0.000345685,0.0009316733,0.0032989758,0.0004474374,0.001203905,0.0005737815,0.0017550973,0.001180277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016892613,0.00008676908,0.00017814085,0.0400668,0.0003099909,0.00024002948,0.00006162821,0.00023837105,0.0012337503,0.00111482,0.014808273,0.9414925],"study_design_scores_gemma":[0.00016961404,0.00024636392,0.0033731426,0.019930469,0.0013587719,0.0022343432,0.00013495974,0.00019276436,0.00068732386,0.0015563517,0.97007465,0.00004119291],"about_ca_topic_score_codex":0.0033735551,"about_ca_topic_score_gemma":0.0085259145,"teacher_disagreement_score":0.0033735551,"about_ca_system_score_codex":0.0006501891,"about_ca_system_score_gemma":0.0014891579,"threshold_uncertainty_score":0.010543764},"labels":[],"label_agreement":null},{"id":"W2002092269","doi":"10.2165/00151829-200504030-00004","title":"Lung Volume Reduction Surgery","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health","keywords":"Medicine; Lung volume reduction surgery; Pharmacy; Lung; Lung volumes; Intensive care medicine; Internal medicine","score_opus":0.4050321787013147,"score_gpt":0.5649801461659483,"score_spread":0.15994796746463358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002092269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012014927,0.99871886,0.00014032733,0.00011905781,0.00012367002,0.000008629973,0.000008444432,0.000003728408,0.0007572724],"genre_scores_gemma":[0.002120661,0.99635124,0.0003318938,0.00024514965,0.0002563317,0.000021370193,0.00003137787,0.0000014250866,0.00064055156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99946636,0.0001393027,0.00009625798,0.00008105974,0.0001807495,0.000036311256],"domain_scores_gemma":[0.9993679,0.00041195977,0.000115396455,0.000015437872,0.000060225313,0.00002904268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008121449,0.00093657634,0.0025341962,0.0032799323,0.0004475229,0.0008552167,0.0008334368,0.00090123335,0.007202385],"category_scores_gemma":[0.0017217573,0.00023092907,0.001108303,0.002420923,0.00081318367,0.0009312552,0.0008241703,0.0016210797,0.0012385425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071056216,0.000056020755,0.00014423899,0.029407438,0.00020933479,0.00015873887,0.000030394585,0.00013495963,0.00042400707,0.0009955071,0.012400948,0.95596737],"study_design_scores_gemma":[0.00033450787,0.0005854733,0.007175753,0.045962654,0.0021554912,0.008394996,0.00027643776,0.0003524381,0.0015074641,0.0042667207,0.92892426,0.000063815954],"about_ca_topic_score_codex":0.0011305517,"about_ca_topic_score_gemma":0.0033046536,"teacher_disagreement_score":0.007202385,"about_ca_system_score_codex":0.00065920927,"about_ca_system_score_gemma":0.001478666,"threshold_uncertainty_score":0.024094403},"labels":[],"label_agreement":null},{"id":"W2048754396","doi":"10.2165/00151829-200403050-00006","title":"Comparative Efficacies and Tolerabilities of Intravenous Azithromycin Plus Ceftriaxone and Intravenous Levofloxacin with Step-Down Oral Therapy for Hospitalized Patients with Moderate to Severe Community-Acquired Pneumonia","year":2004,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Regina General Hospital; Juravinski Hospital","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Azithromycin; Levofloxacin; Ceftriaxone; Community-acquired pneumonia; Internal medicine; Pneumonia; Regimen; Tolerability; Cefuroxime; Surgery; Antibiotics; Adverse effect","score_opus":0.042173874866778094,"score_gpt":0.30665481629047964,"score_spread":0.26448094142370154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048754396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998415,0.000981857,0.00008261991,0.00004714338,0.000015116189,0.0000316103,0.000053933065,0.000005344218,0.00036736386],"genre_scores_gemma":[0.99925596,0.0003262919,0.00012740905,0.000046179983,0.00004254762,0.000020035073,0.00007450361,0.0000023160453,0.00010480712],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999154,0.00045642167,0.000100699785,0.00008098867,0.00009864185,0.000109357585],"domain_scores_gemma":[0.9978974,0.001203272,0.0002908887,0.00011663463,0.000108998844,0.00038282105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011133141,0.00039136648,0.0011612528,0.0002337009,0.00019396315,0.00041319834,0.00044055673,0.00070893264,0.0010253077],"category_scores_gemma":[0.0046898643,0.00027594893,0.00086223555,0.00031467728,0.00043474734,0.0007108699,0.00026740172,0.0010574955,0.0001396133],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7271574,0.012053173,0.053109482,0.0007354387,0.001802834,0.00067258143,0.00058258884,0.0034980292,0.027851194,0.00029549559,0.00038057863,0.17186114],"study_design_scores_gemma":[0.06695512,0.5647765,0.34076893,0.000103701386,0.002989226,0.0008550031,0.00058975525,0.004494634,0.016831422,0.00028913308,0.0012422788,0.00010436841],"about_ca_topic_score_codex":0.00088042294,"about_ca_topic_score_gemma":0.001596958,"teacher_disagreement_score":0.0011612528,"about_ca_system_score_codex":0.0005134321,"about_ca_system_score_gemma":0.00045186642,"threshold_uncertainty_score":0.0058878064},"labels":[],"label_agreement":null},{"id":"W2050091722","doi":"10.2165/00151829-200605020-00006","title":"Pharmacoeconomics of Systemic Therapies for Lung Cancer","year":2006,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pharmacoeconomics; Lung cancer; Docetaxel; Intensive care medicine; Oncology; Pharmacy; Chemotherapy; Cost effectiveness; Cancer; Population; Quality of life (healthcare); Internal medicine; Family medicine; Risk analysis (engineering)","score_opus":0.09016758498454981,"score_gpt":0.49929020798692997,"score_spread":0.40912262300238017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050091722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010648001,0.9986241,0.00014919139,0.00040735072,0.00008743635,0.000005119153,0.000018022423,0.0000035378807,0.00059871736],"genre_scores_gemma":[0.0010290822,0.9978295,0.00033166143,0.00037223822,0.00018780341,0.00000900093,0.000026669866,0.000001066578,0.00021292892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952185,0.00014998546,0.00007176294,0.0000549787,0.00017643152,0.00002504592],"domain_scores_gemma":[0.9985843,0.0010376633,0.0002074079,0.000021399937,0.0001214764,0.000027868437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012183585,0.0008087395,0.0026996352,0.001803775,0.0001816277,0.0008812148,0.0008266321,0.0010641519,0.0036685679],"category_scores_gemma":[0.0020282585,0.0002484368,0.0010415377,0.002607728,0.00037911214,0.0007162092,0.00037514328,0.0016779007,0.0006810455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017501209,0.00008185077,0.00019811091,0.01493079,0.0004970777,0.00015168902,0.000015078821,0.0006591302,0.0004668282,0.0022728564,0.015478847,0.9650728],"study_design_scores_gemma":[0.00048129406,0.00047623654,0.0064999526,0.024468392,0.0027867134,0.0029799123,0.00008764657,0.0008790058,0.0010043207,0.007645141,0.95263493,0.00005637643],"about_ca_topic_score_codex":0.0014714272,"about_ca_topic_score_gemma":0.0043031597,"teacher_disagreement_score":0.0036685679,"about_ca_system_score_codex":0.0009427903,"about_ca_system_score_gemma":0.0012735189,"threshold_uncertainty_score":0.012272596},"labels":[],"label_agreement":null},{"id":"W2056470623","doi":"10.2165/00151829-200504001-00005","title":"Antibacterial Drivers of Resistance","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Antibiotics; Antibacterial activity; Antibiotic resistance; Medicine; Antibacterial agent; Microbiology; Bacteria; Biology; Intensive care medicine","score_opus":0.05122220667360193,"score_gpt":0.3710469637701267,"score_spread":0.31982475709652475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056470623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102107784,0.9961349,0.00044787454,0.0010527406,0.0008728338,0.000005339081,0.000013386208,0.000013779465,0.0013570661],"genre_scores_gemma":[0.0007629503,0.99643815,0.0003869734,0.0007331458,0.00071203825,0.000009689002,0.000024068238,0.0000024172084,0.0009305781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996525,0.000068195266,0.000042664153,0.00006295121,0.00013139329,0.000042298685],"domain_scores_gemma":[0.9994425,0.00027122305,0.00006287506,0.000024173498,0.00014651199,0.000052655058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094614405,0.0013879237,0.0021135944,0.0016536635,0.00047299056,0.0017734423,0.0011863658,0.0020613777,0.0032705613],"category_scores_gemma":[0.001267667,0.00044992665,0.00045465515,0.0013938089,0.0013375195,0.0019591984,0.00093064003,0.00418783,0.0018058101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012118267,0.00009055663,0.00030029463,0.0074836803,0.00007900614,0.00033704576,0.00008494005,0.0004842395,0.005650985,0.015769256,0.077721395,0.89187735],"study_design_scores_gemma":[0.00002243239,0.000047972284,0.0004653615,0.0018539616,0.00006847109,0.0009307847,0.0000693172,0.00013898806,0.0010133869,0.006590763,0.9887806,0.000017933302],"about_ca_topic_score_codex":0.0006968278,"about_ca_topic_score_gemma":0.0017109172,"teacher_disagreement_score":0.0032705613,"about_ca_system_score_codex":0.00093410246,"about_ca_system_score_gemma":0.001300841,"threshold_uncertainty_score":0.010941148},"labels":[],"label_agreement":null},{"id":"W2090299129","doi":"10.2165/00151829-200504020-00001","title":"Improving Survival and Reducing Toxicity with Chemotherapy in Advanced Non-Small Cell Lung Cancer","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Toxicity; Lung cancer; Chemotherapy; Oncology; Pharmacy; Internal medicine; Pharmacology; Intensive care medicine; Family medicine","score_opus":0.036541587243973966,"score_gpt":0.3929872630475807,"score_spread":0.35644567580360675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090299129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027441437,0.9983985,0.00014145108,0.00022237106,0.00010016532,0.000008116877,0.000018478482,0.0000068693125,0.0008296956],"genre_scores_gemma":[0.0014977944,0.997382,0.0002759114,0.00024343503,0.000082496896,0.000010399401,0.00002874564,0.0000011718498,0.00047812273],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999874,0.00002889085,0.00002216941,0.000018784744,0.000045051984,0.000011117499],"domain_scores_gemma":[0.9998266,0.00009974949,0.000034822417,0.0000041321164,0.000026887647,0.000007786755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041685996,0.00062003866,0.001722045,0.001118826,0.00016577475,0.000428729,0.00060993654,0.00064440403,0.002226407],"category_scores_gemma":[0.00054229173,0.00020556359,0.0005531357,0.0014315854,0.00024995502,0.00052826485,0.00025482292,0.0012289739,0.0006764615],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013774478,0.00009445786,0.00015613157,0.013964768,0.00022238736,0.00011527362,0.000029746869,0.00048448954,0.0014074778,0.0011270607,0.01683622,0.96542436],"study_design_scores_gemma":[0.00029076528,0.0005492618,0.003625643,0.0067965477,0.0009727512,0.0021625168,0.00006064749,0.00036249738,0.0015114988,0.0019591125,0.98167795,0.00003084532],"about_ca_topic_score_codex":0.0012429375,"about_ca_topic_score_gemma":0.0035500745,"teacher_disagreement_score":0.002226407,"about_ca_system_score_codex":0.0004486805,"about_ca_system_score_gemma":0.00056722,"threshold_uncertainty_score":0.007448077},"labels":[],"label_agreement":null},{"id":"W2094346814","doi":"10.2165/00151829-200504030-00001","title":"Role of Antimicrobial Agents in the Management??of Exacerbations of COPD","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba","funders":"","keywords":"Medicine; Moraxella catarrhalis; COPD; Exacerbation; Intensive care medicine; Streptococcus pneumoniae; Sputum; Immunology; Internal medicine; Antibiotics; Tuberculosis; Microbiology; Pathology","score_opus":0.09901830156939967,"score_gpt":0.41503733560663414,"score_spread":0.31601903403723447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094346814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056681423,0.9993668,0.000045646033,0.0001596327,0.000083206716,0.000002906982,0.0000058922074,0.0000021563087,0.00027711882],"genre_scores_gemma":[0.0006161887,0.99864584,0.00018086983,0.00023503485,0.00013777695,0.0000051394964,0.000012262968,7.1829726e-7,0.00016626873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993808,0.00015812837,0.00012383665,0.00007849377,0.00022127404,0.000037531925],"domain_scores_gemma":[0.99892455,0.00068354706,0.00020740222,0.00002331849,0.00012372911,0.00003740119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013435046,0.0010579807,0.00352932,0.0020148945,0.00029254664,0.001164696,0.0014379614,0.0016734074,0.0026487126],"category_scores_gemma":[0.0017955798,0.0003720692,0.0012124486,0.0017513869,0.0005703056,0.001466182,0.0006509403,0.002275575,0.0010579474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001607476,0.000072421186,0.00019447196,0.02662655,0.0002886938,0.00021689039,0.00004662482,0.00017393577,0.0006559531,0.001257678,0.011441667,0.9588643],"study_design_scores_gemma":[0.0002507675,0.0003838849,0.003791687,0.033200018,0.0012419226,0.0037298882,0.00015103562,0.00031894146,0.0007929585,0.002640425,0.9534516,0.000046867164],"about_ca_topic_score_codex":0.0014689147,"about_ca_topic_score_gemma":0.0036439348,"teacher_disagreement_score":0.00352932,"about_ca_system_score_codex":0.0004819273,"about_ca_system_score_gemma":0.0010175767,"threshold_uncertainty_score":0.0088608265},"labels":[],"label_agreement":null},{"id":"W2201000183","doi":"10.2165/00151829-200403060-00006","title":"Inhaled Corticosteroids versus Leukotriene Antagonists as First-Line Therapy for Asthma","year":2004,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Fluticasone propionate; Tolerability; Asthma; Salmeterol; Leukotriene receptor; Adverse effect; Inhaled corticosteroids; Leukotriene; Fluticasone; Corticosteroid; Randomized controlled trial; Pharmacology; Anesthesia; Internal medicine","score_opus":0.12532175583857402,"score_gpt":0.43002291526361475,"score_spread":0.3047011594250407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201000183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011724156,0.9993529,0.000035646714,0.000079477875,0.00011158647,0.000003740433,0.000010633849,0.000002450873,0.0002863839],"genre_scores_gemma":[0.0012438612,0.9977836,0.00015491451,0.00022849118,0.00016789723,0.000007466224,0.000029158808,0.0000010750588,0.00038356322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997601,0.000046342375,0.00005368545,0.000043791802,0.00007813407,0.000017956872],"domain_scores_gemma":[0.9996562,0.00018982515,0.00009026051,0.0000060027937,0.000038724385,0.000019091545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005919201,0.0007621715,0.0030081975,0.001527037,0.00020977565,0.00074819947,0.000919378,0.0010605187,0.0044764667],"category_scores_gemma":[0.00075151114,0.00025530372,0.0008439766,0.0018073373,0.00026839966,0.0006963723,0.0003037766,0.0015407644,0.0012470655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007126152,0.00010837893,0.0002216328,0.043044362,0.000550371,0.00026995418,0.000030592022,0.00021910899,0.0017469341,0.00074482244,0.017003633,0.9353476],"study_design_scores_gemma":[0.0012818305,0.0011201893,0.006180385,0.026943978,0.0055384473,0.005263738,0.00014543705,0.00036062294,0.0020297787,0.0013431086,0.94974416,0.000048231766],"about_ca_topic_score_codex":0.0012274915,"about_ca_topic_score_gemma":0.003674958,"teacher_disagreement_score":0.0044764667,"about_ca_system_score_codex":0.0005032279,"about_ca_system_score_gemma":0.0006801861,"threshold_uncertainty_score":0.01497525},"labels":[],"label_agreement":null},{"id":"W2464262759","doi":"10.2165/00151829-200504010-00001","title":"Emphysema in ??1-Antitrypsin Deficiency","year":2005,"lang":"en","type":"review","venue":"Treatments in Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Elastase; Alpha 1-antitrypsin deficiency; Internal medicine; Randomized controlled trial; Neutrophil elastase; Clinical trial; Gastroenterology; Lung; Surgery; Inflammation; Enzyme","score_opus":0.11355301456409672,"score_gpt":0.4357365975797218,"score_spread":0.32218358301562505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464262759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094517716,0.9993388,0.000054350407,0.00008395211,0.00008643475,0.0000041587555,0.000011703854,0.0000025805364,0.0003235465],"genre_scores_gemma":[0.0006569935,0.99860066,0.00016314186,0.00015044761,0.00009255727,0.0000073304027,0.000026787686,5.581148e-7,0.00030141667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998053,0.00003875144,0.000042908992,0.000024887067,0.000074441625,0.000013721091],"domain_scores_gemma":[0.9997297,0.00015313354,0.000065723245,0.000005625605,0.00003409882,0.000011770276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054523326,0.00072822766,0.002501172,0.0020364898,0.00024173241,0.00071277743,0.0007249207,0.00091120094,0.0028370884],"category_scores_gemma":[0.00065991073,0.0002846178,0.0007166844,0.00217115,0.00030868483,0.0006627789,0.00039336682,0.0009617561,0.0010721516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018180664,0.00008591919,0.00035008707,0.053737,0.00037118737,0.00046592506,0.00004174468,0.00020040467,0.0013628545,0.001492046,0.024173908,0.91753715],"study_design_scores_gemma":[0.00025995108,0.0002431318,0.003761722,0.02235725,0.0016544656,0.0047312356,0.00012699657,0.00015802491,0.00091509015,0.0022121374,0.96354705,0.00003283491],"about_ca_topic_score_codex":0.0014994021,"about_ca_topic_score_gemma":0.0036116382,"teacher_disagreement_score":0.0028370884,"about_ca_system_score_codex":0.00038034696,"about_ca_system_score_gemma":0.0007251253,"threshold_uncertainty_score":0.009491026},"labels":[],"label_agreement":null},{"id":"W2467813600","doi":"10.2165/00151829-200605060-00003","title":"Inhaled Glucocorticosteroid and Long-Acting ??2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy","year":2006,"lang":"en","type":"article","venue":"Treatments in Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Inhaler; Agonist; Pharmacy; Pharmacology; Adrenergic beta-Agonists; Formoterol; Salmeterol; Asthma; Internal medicine; Receptor; Budesonide","score_opus":0.03534802152156541,"score_gpt":0.3075114098406725,"score_spread":0.2721633883191071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467813600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75882906,0.18551452,0.0060674767,0.007776965,0.0047481977,0.0011642014,0.001411806,0.0008740392,0.033613652],"genre_scores_gemma":[0.94607,0.020044604,0.009237788,0.0034681836,0.0035486114,0.0006077701,0.0013662211,0.00007820727,0.01557855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996809,0.00005997343,0.000037152757,0.000055636574,0.00009799067,0.00006843898],"domain_scores_gemma":[0.9997516,0.00004409022,0.00003513074,0.000025981124,0.000027627659,0.000115505194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053244573,0.0004511218,0.002597836,0.00045657545,0.0005020868,0.00045743692,0.00055848714,0.00087201106,0.006806597],"category_scores_gemma":[0.00042272743,0.00014730768,0.0010263714,0.00023862063,0.00017574054,0.00040521284,0.00030413043,0.0014925409,0.002056199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045339026,0.005472403,0.016900545,0.0019506741,0.0013112127,0.0043328926,0.00021651307,0.00045292522,0.11089688,0.00081278826,0.025268335,0.78704596],"study_design_scores_gemma":[0.08653029,0.14312191,0.36571494,0.002011359,0.005142248,0.057320464,0.00095085695,0.006306834,0.086308375,0.0022657805,0.24399595,0.00033108488],"about_ca_topic_score_codex":0.00041559202,"about_ca_topic_score_gemma":0.0015238565,"teacher_disagreement_score":0.006806597,"about_ca_system_score_codex":0.00028707678,"about_ca_system_score_gemma":0.0004366862,"threshold_uncertainty_score":0.022770286},"labels":[],"label_agreement":null}]}